The Senate Appropriations Committee recently approved a provision within the FY26 Senate Defense Appropriations Bill that, for the first time, will allow gambling addiction to be an eligible research topic under the Department of Defense's Peer-Reviewed Medical Research Program (PRMRP). This development, championed by Senator Ben Ray Luján (D-NM) and supported by the National Council on Problem Gambling (NCPG) along with industry leaders such as FanDuel, BetMGM, and MGM Resorts International, aims to address a critical research gap that has left military and VA clinicians without adequate tools for early intervention and evidence-based care.
According to the NCPG, servicemembers are twice as likely as civilians to experience gambling problems, and nearly 40% of veterans seeking treatment for gambling addiction report a suicide attempt. The provision's approval responds to the growing recognition of gambling disorder as a significant behavioral health challenge within the military community, comparable to PTSD and depression. Senator Luján emphasized the importance of this step in ensuring that servicemembers and veterans receive the support and understanding they deserve.
This initiative builds upon previous efforts, such as the FY2019 National Defense Authorization Act's mandate for annual gambling disorder screenings. By providing foundational research, the new provision aims to support recovery and improve treatment options. If enacted, the FY26 Defense Appropriations bill will establish the first federally recognized pathway for research into gambling addiction in the military, offering hope for better understanding and treatment options.
The bill now moves to the full Senate for consideration, with the potential to significantly impact the lives of those who have served. For HR vendors serving the military and veteran communities, this development underscores the need for tailored employee assistance programs and behavioral health solutions that address gambling addiction, a condition that has been under-researched and under-treated. As the industry watches the bill's progress, stakeholders should prepare for potential increased demand for specialized training, screening tools, and treatment resources aligned with emerging research findings.
